Healthy adults
Conditions
Interventions
Apply test products A for 4 weeks
Apply test products B for 4 weeks
Apply placebo products for 4 weeks
Sponsors
Miura Clinic, Medical Corporation Kanonkai
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Subjects of men and women aged 20 to 59 (2) Subject with mild or higher atopic dermatitis symptoms (3) Subjects who received sufficient explanation about the purpose and content of the test, had the ability to consent, voluntarily volunteered to participate after understanding it well, and agreed to participate in the test in writing.
Exclusion criteria
Exclusion criteria: (1) Subjects using oral medications (steroids, antiallergic drugs) and topical steroids for atopic dermatitis (2) Subjects with a history of diabetes mellitus, liver disease, renal disease, gastrointestinal disease, cardiac disease, respiratory disease, peripheral vascular disease, disease affecting the secretion of adrenal corticosteroids, or other serious diseases. (3) Subjects who have undergone gastrointestinal surgery (4) Subjects with diseases currently being treated. (5) Subjects who are allergic to food and drugs (6) Subjects with significant abnormalities in skin manifestations at the test site or with symptoms of severe atopic dermatitis. (7) Subjects whose skin condition changes drastically due to irregular menstruation or menstruation. (8) Female subjects wishing to become pregnant while participating in this study, pregnant (including those who may be pregnant) or lactating female subjects. (9) Subjects who play intense sports and subjects who are on a diet. (10) Subjects with extremely irregular eating habits (11) Subjects who may be exposed to excessive ultraviolet light during the study period. (12) Subjects who visit beauty salons for skin care (13) Subjects who ingest health foods (including foods for specified health uses and foods with functional claims) and designated quasi-drugs that affect the skin or atopic dermatitis during the study period (14) Subjects who are continuously treated with medications (including OTC, prescription drugs) (15) Subjects who drink more than 40 g of pure alcohol per day, who consume excessive alcohol, or who are unable to abstain from alcohol on the day before the testSubjects who are unable to perform the testing procedures to be conducted during the study period as specified (e.g., questionnaire responses) (16) to (18) are listed in the "Other related information" column
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Physician's findings Post-use satisfaction questionnaire | — |
Countries
Japan
Contacts
Public ContactMakoto Terashima
Oneness Support Co., Ltd. Clinical Trial Division
Outcome results
None listed